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Background: Although the evaluation of caesarean delivery rates has been suggested as one of the most
important indicators of quality in obstetrics, it has been criticized because of its controversial ability to capture
maternal and neonatal outcomes. In an “ideal” process of labor and delivery auditing, both caesarean (CD) and
assisted vaginal delivery (AVD) rates should be considered because both of them may be associated with an
increased risk of complications.
The aim of our study was to evaluate maternal and neonatal outcomes according to the outlier status for case-mix
adjusted CD and AVD rates in the same obstetric population.
Methods: Standardized data on 15,189 deliveries from 11 centers were prospectively collected. Multiple logistic
regression was used to estimate the risk-adjusted probability of a woman in each center having an AVD or a CD.
Centers were classified as “above”, “below”, or “within” the expected rates by considering the observed-to-expected
rates and the 95% confidence interval around the ratio. Adjusted maternal and neonatal outcomes were compared
among the three groupings.
Results: Centers classified as “above” or “below” the expected CD rates had, in both cases, higher adjusted
incidence of composite maternal (2.97%, 4.69%, 3.90% for “within”, “above” and “below”, respectively; p = 0.000) and
neonatal complications (3.85%, 9.66%, 6.29% for “within”, “above” and “below”, respectively; p = 0.000) than centers
“within” CD expected rates. Centers with AVD rates above and below the expected showed poorer and better
composite maternal (3.96%, 4.61%, 2.97% for “within”, “above” and “below”, respectively; p = 0.000) and neonatal
(6.52%, 9.77%, 3.52% for “within”, “above” and “below”, respectively; p = 0.000) outcomes respectively than centers
with “within” AVD rates.
Conclusions: Both risk-adjusted CD and AVD delivery rates should be considered to assess the level of obstetric
care. In this context, both higher and lower-than-expected rates of CD and “above” AVD rates are significantly
associated with increased risk of complications, whereas the “below” status for AVD showed a “protective” effect on
maternal and neonatal outcomes.
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Quality of care is an important topic in modern obstet-
rics of which risk-adjusted caesarean delivery (CD) rate
is often used as an indicator, with the implicit assump-
tion that low rates may reflect evidence-based inter-
vention [1-8].
Although the evaluation of risk-adjusted CD rates is
an important factor in quality assessment, it is just one
of the elements to be considered in the process of labor
and delivery auditing. In this regard, a comprehensive
assessment should encompass both maternal and neonatal
outcomes according to mode of delivery [4]. Several stud-
ies focused on the association between institutional ad-
justed CD rates and outcomes reporting controversial
results. In their retrospective cohort study on 748,604 low
risk singleton pregnancies, Gould et al. observed that neo-
natal morbidity (birth asphyxia and intensive care-
therapeutic interventions) was increased both in low- and
high-CD rate hospitals [5]. Bailit et al., considering the
Washington State Birth Events Records for 1995 and
1996, showed that asphyxiated infants were likely to be
delivered by caesarean in hospitals in which CD rates were
above the predicted range [6]. In another study, the same
authors showed a mixed picture for hospitals with CD
rates above the expected, with some poorer and some im-
proved maternal and neonatal outcomes [7]. Srinivas et al.
evaluated both maternal and neonatal composite out-
comes according to institutional adjusted CD rate in a
population-based cohort from 401 hospitals. Their
conclusion was that lower-than-expected risk-adjusted
CD rates were associated with an increased risk of ma-
ternal or neonatal complications and that above than
expected risk-adjusted CD rates did not result in im-
proved outcomes [8].
All the above mentioned studies have however limited
their attention to the CD rate. None of them has evalu-
ated the association between the risk of adverse maternal
and neonatal outcomes and the outlier status for both
adjusted caesarean and assisted vaginal delivery rates
(AVD) in the same obstetric population. Including the
rate of assisted vaginal delivery in this analysis may be
crucial in the assessment of quality of care. In fact, insti-
tutions with low frequencies of risk-adjusted CD rates
might have, as a balance, high adjusted AVD rates, po-
tentially associated with adverse outcomes [9]. Limiting
the evaluation of the obstetrics performance to the CD
rates could therefore be misleading and not reflect the
true outcomes of that center.
The aim of our study, carried out on more than 15,000
deliveries of 11 different centers of Friuli Venezia Giulia,
a north-eastern region of Italy, was to determine the
prevalence of adverse maternal and neonatal outcomes
according to the mode of delivery. We tested the hy-
pothesis that institutions with risk-adjusted AVD andCD rates above or below the expected would have higher
and lower rates, respectively, of maternal and neonatal
complications.
Methods
We prospectively collected data on all deliveries occur-
ring in the 11 hospitals of Friuli Venezia Giulia in a
period of 18 months between July 2006 and December
2007. Friuli Venezia Giulia is a region of North-Eastern
Italy accounting roughly for 10,000 deliveries per year
with one of the lowest overall regional CD rate in Italy
(23.4% in 2010). Virtually all births of the region were
included in the study, given the very low rate of home
births and the absence of midwifery-led centers in the
area. The Institutions of the region, referred to as A to
M, are level one units, serving low risk pregnancies, with
the exception of centers I and M that are level three
units (range 369–1,810 deliveries/year/unit).
To eliminate the potential bias generated by different
definitions and heterogeneous collection of data, we cre-
ated a regional computerized database considering ma-
ternal characteristics (maternal age and pre-pregnancy
body mass index-BMI), variables related to pregnancy
(parity, gestational age at delivery, singleton or multiples,
presence of previous CD), antenatal clinical risk factors,
mode of delivery and short term neonatal and maternal
outcomes. Data on pregnancies were prospectively col-
lected at the time of delivery and before maternal/neo-
natal discharge and were systematically reviewed every
month by the referent obstetrician of each center.
Special attention was devoted to completeness and
accuracy of data. During the study period, two of the
authors (GM and SA) organized periodical multicenter
meetings to discuss the results and provide assistance.
The study was approved by the institutional review
board of the coordinating center (Institute for Mater-
nal and Child Health – IRCCS Burlo Garofolo, Trieste,
project 86/05 – February 28, 2007) and access to the
data was approved by all hospital trust administrations.
According to the Italian law on privacy, data were
anonymized at every institution where each patient
was assigned a unique identifier.
Short term maternal and neonatal complications were
analyzed both as single and combined complications (life
threatening, non-life threatening and composite).
Life threatening maternal complications were defined as
follow (criteria modified from McMahon [10]): 1. Major
PPH (post-partum hemorrhage greater than 1000 mL or
requiring blood transfusion) [11]; 2. Post-partum hys-
terectomy; 3. Obstetric wound hematoma requiring
re-intervention; 4. Thromboembolic disease; 5. Uterine
rupture. Non-life threatening maternal morbidities in-
cluded: 1. Minor PPH (post-partum hemorrhage between
500 and 1000 mL) [11]; 2. III-IV degree perineal tears; 3.
Maso et al. BMC Pregnancy and Childbirth  (2015) 15:20 Page 3 of 13Asymptomatic wound dehiscence; 4. Endometritis or
pyrexia needing antibiotic treatment; 5. Bowel or blad-
der injury; 6. Anaesthesiological complications; 7. Any
other condition requiring admission to intensive care
unit (ICU).
Life threatening neonatal complications (criteria modi-
fied from Fong [12]) included: 1. Mortality within 7 days
of life; 2. Mortality within 28 days; 3. Abnormal neurologic
status (encephalopathy as defined by Sarnat and Sarnat
[13]), neonatal convulsions and intracranial hemorrhage
(including all classes of intraventricular hemorrhage, epi-
dural hemorrhage, and subdural hemorrhage). Non-life
threatening neonatal morbidities were assessed as follow:
1. Pulmonary disorders, including transient tachypnoea of
the newborn and respiratory distress syndrome, as defined
by Hjalmarson [14]; 2. Bacterial infections including pneu-
monia and sepsis, diagnosed clinically with or without
confirmation by blood cultures; 3. Umbilical artery cord
pH at birth less than 7.00; 4. Umbilical artery cord base
deficit greater than 12 mmol/L at birth; 5. Apgar score less
than 7 at five minutes in term newborns; 6. Any other
condition (birth trauma included) requiring neonatal in-
tensive care (NICU) admission in term newborns for more
than 24 hours (37–42 weeks/birth weight >2500 grams).
Incidence of complications was analyzed for all cases
and divided into spontaneous vaginal (SVD), assisted
vaginal (AVD), overall vaginal (VD) and caesarean deliv-
eries (CD). Both women and newborns could have more
than one complication, thus the total number of single
complications is higher than the number of women or
newborns with complications. In case of multiple preg-
nancies, if one of the newborns had a complication, this
was considered as a neonatal complication. Only cases
with complete data on all of the above indicated vari-
ables were included in the final analysis. Pregnancies
complicated by antepartum stillbirths and/or life-
threatening fetal congenital anomalies and deliveries
with infants weighting less than 500 grams and/or below
24 weeks’ gestation were excluded to avoid potential
bias in the evaluation of the outcomes.
Associations between type of delivery (CD vs. SVD,
CD vs. VD and AVD vs. SVD) and single or composite
complications were analyzed calculating crude and ad-
justed risk ratios (RRs) and p values, resulting from
log-binomial regressions [15]. Considering that we had
approximately 50 comparisons, we adopted a conservative
Bonferroni correction dividing the significance level of
0.05 by 50: thus we considered p < 0.001 as statistically
significant.
CD and AVD rates were adjusted for maternal age
(reference 20–24 years, <20 years, 25–29 years, 30–35
years, >35 years), maternal pre-pregnancy BMI (refer-
ence 18.5-24.9 kg/m2, <18.5 kg/m2, 25 – 29.9 kg/m2,
≥30 kg/m2) [16], gestational age at delivery (reference37–41 weeks, <30 weeks, 30–36 weeks, >41 weeks)
classification of pregnancy at risk (reference no risk,
low/intermediate risk, high risk), parity (reference
multiparous, nulliparous), gestations (reference single-
ton, twin), presentation (reference cephalic, other),
presence of previous CD (reference no past CD, one,
more than one) newborn birth weight (reference 2,500-
4,000 grams, <1,000 grams, 1,000-1,499 grams, 1,500-
2,499 grams, >4,000 grams). Pregnancy was classified
as at low-intermediate or high risk on the basis of the
following definitions: 1. Low risk: if no pre-existing or
ante partum risk factor was identified; 2. Intermediate
risk: presence of pre-existing maternal medical condi-
tions complicating the pregnancy, but not representing
per se an absolute indication to CD or induction of
labor (e.g. chronic hypertension, pregnancy-associated
hypertension, gestational diabetes, obstetric cholestasis,
polyhydramnios and Rh-isoimmunization); 3. High risk:
presence of pre-existing maternal diseases or other ob-
stetric conditions suggesting the need for delivery, such
as HIV infection, pre-existing diabetes, severe pre-
eclampsia, placenta previa, oligohydramnios and intra-
uterine growth restriction defined as fetal abdominal
circumference or estimated fetal weight less than the
10th centile [7]. In case of a multiple pregnancy, we con-
sidered the lowest newborn birth weight. Finally, given
the acknowledged high risk of complications related to
the delivery in the presence of impeding maternal and
fetal compromise, the degree of urgency was also consid-
ered into the risk-adjustment (reference maternal and fetal
compromise, no maternal and fetal compromise) [17].
Following these adjustments, we calculated for each of
the 11 centers the expected AVD and CD rates.
According to the methodology adopted by Bailit et al.,
a logistic regression model was initially developed to
generate the predicted probability of operative deliveries
(CD and AVD) for each patient. Second, the probabilities
of operative deliveries for all patients were added to-
gether for each center to obtain the predicted number of
CDs and AVDs for that institution. We then divided
these predicted numbers of deliveries by the total num-
ber of patients who were delivered at that hospital to ob-
tain the institutional expected caesarean and assisted
vaginal delivery rates. Units were herein classified by
evaluating the ratio of observed-to-expected rates and
considering the 95% confidence interval (CI) around the
ratio. If the 95% CI of the resulting ratio included 1, the
center was classified as within the expected. If the 95%
CI was above or below 1, the centers were respectively
classified as above or below the expected [7]. Maternal
and neonatal outcomes were thus analyzed according to
the outlier status of the centers as within, above and
below the expected rates. The incidences of maternal
and neonatal complications were adjusted by maternal
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parity, fetal presentation, number of fetuses, presence of
previous CD (no, one, more than one), gestational age at
delivery and neonatal birth weight and delivery grade of
urgency. Finally, given the potential influences of obstetric
volume and the organization of newborn care on out-
comes, complication rates were also adjusted by consider-
ing the number of deliveries per center (reference ≥1000
deliveries/year, <1000 deliveries/year) and the presence of
a Neonatal Intensive Care Unit (reference available, non-
available) [18-20]. Differences among adjusted outcomes
were evaluated with the analysis of variance (ANOVA)
with Bonferroni corrections for single comparisons be-
tween within vs. above and within vs. below the expected
CD and AVD rates. Finally, considering we already had
applied the correction to each outcome, we additionally
corrected for the number of outcomes and considered as
significant p values below 0.003.
All statistical analyses were performed using Stata/IC
11.2 software (StataCorp, College Station, TX, USA).
Results
From a total number of 15,726 pregnancies, we excluded
from the analysis cases with life-threatening fetal con-
genital anomalies (18 cases), all antepartum stillbirths
(16) and incomplete records, regarding maternal age
(18), BMI (441), classification of pregnancy at risk (10),
neonatal complications (29) and maternal complications
(5). Analyses were consequently carried out on 15,189
pregnancies.
Distributions of non-missing independent variables
and CD/AVD rates were similar across the analyzed and
the excluded records (data not shown).
CD and AVD rates by institution ranged from 14.3%
to 34.1% and from 3.9% to 10.2% (Figure 1). Four hospi-
tals (36.4%: B, D, L and M) had adjusted CD rates above
the predicted confidence interval; four centers (36.4%: A,Figure 1 Institutional caesarean and assisted vaginal delivery rates (pF, H, I) were below the interval and three centers (27.2%:
C, E and G) fell within the interval for their patient
population. With regard to AVD, two hospitals (18.3%:
G and M) had adjusted rates above the predicted confi-
dence interval; three (27.2%: E, H, L) were below the
interval, and six (54.5%: A, B, C, D, F, I) were within the
interval.
Analysis of maternal and neonatal outcomes according to
mode of delivery
The incidence and crude and adjusted RRs of maternal
and neonatal outcomes according to mode of delivery
are listed in Tables 1 and 2. Outcomes varied substan-
tially by mode of delivery and some of them were obvi-
ously associated with only one mode of delivery (e.g.
III-IV degree perineal tears). If a condition was inher-
ent of a mode of delivery, then no comparative analysis
was performed.
We assessed the outcomes by mode of delivery with
bivariate and multivariate analyses in order to control
for all possible confounders that can be both related to
the need of an operative delivery and to the increased
risk of adverse outcomes.
Considering either SVD or VD (SVD plus AVD) as the
reference, CD was associated with a significantly higher
risk of endometritis-infection (adjusted RRs 4.74 and
4.33 respectively) and selective neonatal complications
such as pulmonary disorders (adjusted RRs 2.07 and
2.12, respectively). The risk of Apgar score less than 7 at
five minutes was higher in CDs than SVDs (adjusted RR
2.06), and any other condition requiring NICU admis-
sion in neonates at term occurred more frequently in
CDs than VDs (adjusted 1.99). In regard to the “protect-
ive effect”, CD was associated with a better composite
maternal outcome for life threatening complications
than VD. However the difference was not significant if
the comparison considered only SVD.ercentage). Centers are reported in capital letters.
Table 1 Incidence of outcomes (individual and composite) by mode of delivery
Overall SVD CD AVD
n = 15,189 n = 10,410 n = 3,638 n = 1,141
Maternal complications n (%) n (%) n (%) n (%)
Major PPH 61 (0.40) 30 (0.29) 20 (0.55) 11 (0.96)
Hysterectomy 8 (0.05) 3 (0.03) 5 (0.14) 0 (0.00)
Wound hematoma 49 (0.32) 30 (0.29) 9 (0.25) 10 (0.88)
TED 6 (0.04) 2 (0.02) 3 (0.08) 1 (0.09)
Uterine rupture 2 (0.01) 0 (0.00) 2 (0.05) 0 (0.00)
Life threatening composite 111 (0.73) 59 (0.57) 32 (0.73) 20 (1.75)
Minor PPH 369 (2.43) 232 (2.23) 90 (2.47) 47 (4.12)
III-IV degree tears 50 (0.33) 39 (0.37) 0 (0.00) 11 (0.96)
Wound Dehiscence 25 (0.16) 12 (0.12) 10 (0.27) 3 (0.26)
Endometritis 69 (0.45) 23 (0.22) 42 (1.15) 4 (0.35)
Bowel/bladder injury 4 (0.03) 0 (0.00) 4 (0.11) 0 (0.00)
Anaesthesiological 7 (0.05) 4 (0.04) 2 (0.05) 1 (0.09)
Other* 19 (0.13) 6 (0.06) 12 (0.33) 1 (0.09)
Non-life threatening composite 485 (3.19) 283 (2.72) 142 (3.90) 60 (5.26)
Overall composite 596 (3.92) 342 (3.29) 174 (4.78) 80 (7.01)
Neonatal complications n (%) n (%) n (%) n (%)
Mortality <7 days 17 (0.11) 3 (0.03) 13 (0.36) 1 (0.09)
Mortality <28 days 13 (0.09) 4 (0.04) 6 (0.16) 3 (0.26)
Neurologic symptoms 38 (0.25) 6 (0.06) 29 (0.80) 3 (0.26)
Life threatening composite 47 (0.31) 9 (0.09) 33 (0.91) 5 (0.44)
Pulmonary disorders 250 (1.65) 84 (0.81) 156 (4.29) 10 (0.88)
Bacterial infections 98 (0.65) 38 (0.37) 58 (1.59) 2 (0.18)
pH < 7.00 74 (0.49) 25 (0.24) 29 (0.80) 20 (1.75)
BD > 12 mmol/L 204 (1.34) 113 (1.09) 41 (1.13) 50 (4.38)
Apgar < 7 118 (0.78) 37 (0.36) 59 (1.62) 22 (1.93)
Other** 773 (5.09) 284 (2.73) 445 (12.23) 44 (3.86)
Non-life threatening composite 973 (6.41) 416 (4.00) 464 (12.75) 93 (8.15)
Overall composite 1,020 (6.72) 425 (4.08) 497 (13.66) 98 (8.59)
Footnotes: SVD, spontaneous vaginal delivery; AVD, assisted vaginal delivery; CD, caesarean delivery; VD vaginal delivery ; PPH, post-partum hemorrhage; TED,
thromboembolic disease; BD, base deficit.
*Any other condition requiring Intensive Care Unit admission.
**Any other condition requiring Neonatal Intensive Care Unit admission in term neonates (37–42 weeks).
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higher risk of major and minor PPH (adjusted RRs 2.41
and 1.41, respectively), III-IV degree tears (adjusted RRs
2.26) and life threatening, non-life threatening and over-
all composite adverse maternal outcomes (adjusted RRs
2.24, 1.57 and 1.67, respectively).
As for the neonate, AVD was associated with a higher
risk of mortality within 28 days (adjusted RRs 7.12), ar-
terial cord pH less than 7.00 and base deficit greater
than 12 mmol/l (adjusted RRs 7.02 and 3.28, respect-
ively), Apgar score less than 7 at five minutes (adjusted
RR 5.00), and life threatening, non-life threatening andoverall composite neonatal morbidities (adjusted RRs
3.31, 1.78 and 1.92 respectively).
Multivariate Analysis of Maternal and Neonatal Outcomes
According to Outlier Status
Adjusted maternal and neonatal outcomes according
to the outlier status for CD and AVD are described in
Tables 3 and 4, respectively.
With regard to caesarean deliveries, the “above” group
had worse maternal outcomes if compared to the “within”
reference group. The incidence of major and minor PPH,
hysterectomy, III-IV degree tears, endometritis-infection,
Table 2 Risk ratios for outcomes (individual and composite) by mode of delivery
CD vs. SVD CD vs. VD AVD vs. SVD
Maternal complications Crude RR Adj RR Crude RR Adj RR Crude RR Adj RR
Major PPH 1.91 (1.08-3.35) 0.81 (0.38-1.70) 1.55 (0.91-2.64) 0.52 (0.25-1.07) 3.35 (1.68-6.66) 2.41 (1.20-4.83)§
Hysterectomy 5.29 (1.27-22.13) 1.68 (0.27-10.54) 5.29 (1.27-22.13) 1.39 (0.44-8.16) - -
Wound hematoma 0.86 (0.41-1.81) 0.32 (0.07-1.48) 0.71 (0.35-1.47) 0.28 (0.07-1.14) 3.04 (1.49-6.20) 2.09 (0-97-4.51)
TED 4.29 (0.71-25.68) 0.31 (0.06-1.45) 3.18 (0.64-15.72) 0.45 (0.06-2.90) 4.56 (0.41-50.27) 2.10 (0.97-4.55)
Uterine rupture - - - - - -
Life threatening composite 1.57 (1.02-2.41) 0.61 (0.36-1.03) 1.30 (0.86-1.95) 0.49 (0.29-0.84) 3.18 (1.92-5.25)§ 2.24 (1.46-.3.45)§
Minor PPH 1.11 (0.87-1.41) 0.66 (0.31-1.37) 0.71 (.129) 0.61 (0.28-1.32) 1.85 (1.36-2.51)§ 1.41 (1.02-1.93)§
III-IV degree tears - - - - 3.47 (1.78-6.76)§ 2.26 (1.13-4.52)§
Wound Dehiscence 2.38 (1.03-5.51) 1.15 (0.16-1.28) 2.12 (0.95-4.71) 0.97 (0.11-8.59) 2.28 (0.64-8.07) 2.14 (0.58-7.91)
Endometritis 5.22 (3.15-8.68)§ 4.74 (2.53- 8.87)§ 4.94 (3.05-8.00)§ 4.33 (2.39-7.84)§ 1.59 (0.55-4.58) 1.80 (0.79-4.08)
Bowel/bladder injury - - - - - -
Anaesthesiological 1.43 (0.26-7.81) 0.65 (0.16-2.55) 1.27 (0.25-6.54) 0.56 (0.12-2.46) 2.28 (0.26-20.39) 1.95 (0.21-18.03)
Other* 5.72 (2.15-15.24)§ 1.59 (0.62-4.09) 5.44 (2.14-13.81)§ 0.79 (0.40-1.55) 1.52 (0.18-12.62) 1.09 (0.12-9.76)
Non-life threatening composite 1.44 (1.18-1.76)§ 0.85 (0.44-1.64) 1.32 (1.09-1.60) 0.92 (0.72-1.81) 1.96 (1.49-2.57)§ 1.57 (1.11-2.23)§
Overall composite 1.46 (1.22-1.74)§ 1.04 (0.61-1.80) 1.31 (1.01-1.56) 0.77 (0.39-1.53) 2.13 (1.69-2.70)§ 1.67 (1.22-2.27)§
Neonatal complications Crude RR Adj RR Crude RR Adj RR Crude RR Adj RR
Mortality <7 days 12.40 (3.54-43.49)§ 3.04 (0.65-14.31) 10.32 (3.37-31.63)§ 2.50 (0.44-14.13) 3.04 (0.32-29.21) 3.61 (0.50-25.08)§
Mortality <28 days 4.29 (1.21-15.20) 0.68 (0.28-1.63) 2.72 (0.92-8.09) 0.51 (0.13-2.03) 6.84 (1.53-30.54) 7.12 (1.51-33.68)§
Neurologic symptoms 13.83 (5.75-33.28)§ 2.34 (0.86-6.36) 10.23 (4.85-21.59)§ 1.87 (0.64-5.43) 4.56 (1.14-18.22) 2.77 (0.69-11.06)
Life threatening composite 11.55 (5.53-24-10)§ 3.30 (0.85-12.78) 8.20 (4.39-15.30)§ 1.55 (0.35-6.97) 5.30 (1.78-15-78) 3.31 (1.59-6.90)§
Pulmonary disorders 5.31 (4.09-6.91)§ 2.07 (1.17-3.66)§ 5.27 (4.09-6.79)§ 2.12 (1.17-3.84)§ 1.08 (0.57-2.09) 0.81 (0.45-1.48)
Bacterial infections 4.37 (2.91-6.56)§ 1.34 (0.57-3.14) 4.60 (3.08-6.88)§ 1.43 (0.65-3.13) 0.48 (0.16-1.99) 0.42 (0.05-3.72)
pH < 7.00 3.32 (1.95-5.66)§ 1.41 (0.54-3.69) 2.05 (1.29-3.26) 0.78 (0.31-2.00) 7.30 (4.07-13.10)§ 7.02 (4.13-11.95)§
BD > 12 mmol/L 1.04 (0.73-1.48) 0.49 (0.24-0.97) 0.80 (0.57-1.12) 0.35 (0.16-0.77) 4.04 (2.91-5.60)§ 3.28 (2.01-5.37)§
Apgar < 7 4.56 (3.03-6.87)§ 2.06 (1.16-3.67)§ 3.17 (2.22-4.55)§ 1.01 (0.62-1.64) 5.43 (3.21-9.16)§ 5.00 (2.60-9.61)§
Other** 4.48 (3.88-5.18)§ 1.05 (0.81-1.36) 4.31 (3.75-4.94)§ 1.99 (1.62-2.43)§ 1.41 (1.04-1.93) 1.12 (0.79-1.57)
Non-life threatening composite 3.21 (2.83-3.65)§ 0.94 (0.75-1.18) 2.92 (2.59-3.29)§ 0.92 (0.73-1.17) 2.05 (1.65-2.54)§ 1.78 (1.42-2.22)§
Overall composite 3.35 (2.96-3.79)§ 0.95 (0.76-1.19) 3.01 (2.68-3.39)§ 0.89 (0.70-1.12) 2.10 (1.70-2.60)§ 1.92 (1.45-2.25)§
Footnotes: Risk ratios adjusted by maternal age, maternal body mass index, gestational age at delivery, pregnancy at risk, parity, fetal presentation, number of
fetuses, presence of previous CD, neonatal birth weight, grade of urgency (e.g. maternal or fetal compromise requiring immediate delivery).
RR, risk ratios; SVD, spontaneous vaginal delivery; AVD, assisted vaginal delivery; CD, caesarean delivery; VD vaginal delivery; Adj, adjusted; PPH, post-partum
hemorrhage; TED, thromboembolic disease; BD, base deficit.
*Any other condition requiring Intensive Care Unit admission.
**Any other condition requiring Neonatal Intensive Care Unit admission in term neonates (37–42 weeks).
§p < .001.
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unit, as well as life threatening, non-life threatening and
overall composite maternal adverse outcomes, was signifi-
cantly higher in centers with above the expected CD rates.
This group showed also significantly higher frequencies
of almost all the neonatal complications (except for cord
pH <7).
It is of interest to note that similar results were also
observed in centers with CD rates below the expected
(Table 3).
Higher rates of selected maternal complications (PPH,
wound hematoma, uterine rupture, III-IV degree tears,anaesthesiological complications, and non-life threatening
and overall composite maternal adverse outcomes) were
also observed in centers with AVD rates above the expected.
This group had also significantly higher rates of unfavorable
neonatal outcomes for almost all the considered conditions.
Inversely, institutions with an AVD rate below the ex-
pected had significantly better maternal and neonatal out-
comes than the “within” AVD rates institutions (Table 4).
Discussion
There is a worldwide growing debate on quality assess-
ment in obstetric care and this issue represents an
Table 3 Adjusted outcomes (individual and composite) by caesarean delivery rates outlier status
Caesarean delivery outlier
Within expected Above expected Below expected
Maternal complications % (95% CI) % (95% CI) % (95% CI)
Major PPH 0.20 (0.20-0.21) 0.59 (0.57-0.62) 0.37 (0.35-0.39)
Hysterectomy 0.03 (0.03-0.04) 0.09 (0.07-0.11) 0.04 (0.03-0.04)
Wound hematoma 0.32 (0.31-0.33) 0.32 (0.31-0.33) 0.33 (0.32-0.33)
TED 0.07 (0.05-0.08) 0.03 (0.03-0.03) 0.03 (0.03-0.04)
Uterine rupture 0.01 (0.01-0.01) 0.01 (0.01-0.01) 0.01 (0.01-0.01)
Life threatening composite 0.53 (0.51-0.55) 0.92 (0.89-0.94) 0.71 (0.68-0.73)
Minor PPH 1.85 (1.81-1.89) 2.71 (2.65-2.77) 2.51 (2.47-2.56)
III-IV degree tears 0.28 (0.27-0.28) 0.35 (0.34-0.36) 0.34 (0.33-0.35)
Wound Dehiscence 0.17 (0.17-0.18) 0.16 (0.15-0.17) 0.16 (0.16-0.17)
Endometritis-Infection 0.44 (0.43-0.46) 0.52 (0.50-0.54) 0.42 (0.41-0.44)
Bowel or bladder injury 0.02 (0.02-0.03) 0.03 (0.03-0.03) 0.03 (0.03-0.03)
Anaesthesiological 0.05 (0.04-0.05) 0.05 (0.04-0.05) 0.05 (0.04-0.05)
Other* 0.09 (0.08-0.10) 0.16 (0.14-0.17) 0.12 (0.11-0.13)
Non-life threatening composite 2.46 (2.42-2.51) 3.82 (3.75-3.89) 3.20 (3.15-3.25)
Overall composite 2.97 (2.92-3.02) 4.69 (4.61-4.78) 3.90 (3.85-3.96)
Neonatal complications % (95% CI) % (95% CI) % (95% CI)
Mortality <7 days 0.03 (0.03-0.04) 0.16 (0.14-0.19) 0.11 (0.09-0.13)
Mortality <28 days 0.05 (0.05-0.06) 0.13 (0.10-0.16) 0.08 (0.06-0.10)
Neurologic symptoms 0.06 (0.05-0.07) 0.40 (0.34-0.46) 0.21 (0.18-0.24)
Life threatening composite 0.13 (0.10-0.16) 0.53 (0.44-0.62) 0.23 (0.20-0.26)
Pulmonary disorders 0.66 (0.61-0.70) 2.24 (2.08-2.39) 1.60 (1.50-1.70)
Bacterial infections 0.46 (0.42-0.49) 0.94 (0.84-1.04) 0.58 (0.54-0.61)
pH < 7.00 0.66 (0.62-0.71) 0.35 (0.33-0.37) 0.48 (0.47-0.50)
BD > 12 mmol/L 1.22 (1.19-1.26) 1.30 (1.27-1.34) 1.41 (1.38-1.44)
Apgar < 7 0.59 (0.57-0.61) 0.99 (0.89-1.09) 0.70 (0.66-0.73)
Other** 1.74 (1.57-1.91) 8.20 (7.75-8.66) 4.71 (4.46-4.95)
Non-life threatening composite 3.56 (3.33-3.79) 9.08 (8.62-9.54) 6.13 (5.88-6.37)
Overall composite 3.85 (3.67-4.02) 9.66 (9.31-10.01) 6.29 (6.10-6.48)
Footnotes. Outcomes were adjusted by maternal age, maternal body mass index, gestational age at delivery, pregnancy at risk, parity, fetal presentation, number
of fetuses, presence of previous CD, neonatal birth weight, grade of urgency (e.g. maternal or fetal compromise requiring immediate delivery) and cluster
variables: centers with NICU and obstetric volume per center (number of deliveries/year).
PPH, post-partum hemorrhage; TED, thromboembolic disease; BD, base deficit.
*Any other condition requiring admission to Intensive Care Unit.
**Any other condition requiring admission to Neonatal Intensive Care Unit in term neonates (37–42 weeks).
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agenda [21-24].
Whether processes or outcome measures are used
as markers of quality, an ideal assessment should en-
compass variables that are clinically relevant, easy to
define and observe. Although the evaluation of CD
rates – according to their adjusted rates – has been
suggested as one of the most important indicators of
quality, it has been criticized because of its contro-
versial ability to capture both maternal and neonatal
outcomes [8].Our multicenter study is the first to determine the ad-
justed incidence of adverse maternal and neonatal out-
comes according to institutional outlier status for both
adjusted AVD and CD rates.
We observed that both centers with CD rates above
or below the expected had a higher incidence of almost
all the maternal and neonatal clinically significant
adverse outcomes. Moreover, centers with higher-than-
expected AVD rates showed higher incidence of compli-
cations, whereas those with a rate of AVD below the
expected had a significantly lower rate of selected and
Table 4 Adjusted outcomes (individual and composite) by assisted vaginal delivery rates outlier status
Assisted vaginal delivery outlier
Within expected Above expected Below expected
Maternal complications % (95% CI) % (95% CI) % (95% CI)
Major PPH 0.43 (0.41-0.45) 0.49 (0.47-0.51) 0.20 (0.19-0.22)
Hysterectomy 0.06 (0.05-0.07) 0.04 (0.03-0.04) 0.04 (0.03-0.05)
Wound hematoma 0.31 (0.31-0.33) 0.34 (0.33-0.36) 0.32 (0.31-0.34)
TED 0.04 (0.03-0.04) 0.03 (0.02-0.03) 0.06 (0.05-0.07)
Uterine rupture 0.01 (0.01-0.01) 0.02 (0.02-0.02) 0.01 (0.01-0.01)
Life threatening composite 0.76 (0.74-0.78) 0.80 (0.78-0.83) 0.53 (0.51-0.55)
Minor PPH 2.38 (2.34-2.42) 2.97 (2.91-3.04) 1.91 (1.86-1.95)
III-IV degree tears 0.32 (0.31-0.33) 0.39 (0.37-0.40) 0.29 (0.28-0.30)
Wound Dehiscence 0.17 (0.16-0.17) 0.15 (0.14-0.15) 0.17 (0.16-0.18)
Endometritis-Infection 0.46 (0.45-0.47) 0.46 (0.44-0.48) 0.43 (0.41-0.44)
Bowel or bladder injury 0.03 (0.03-0.03) 0.03 (0.02-0.03) 0.03 (0.02-0.03)
Anaesthesiological 0.04 (0.04-0.04) 0.05 (0.05-0.06) 0.05 (0.05-0.05)
Other* 0.13 (0.12-0.14) 0.14 (0.12-0.16) 0.10 (0.09-0.12)
Non-life threatening composite 3.22 (3.17-3.26) 3.83 (3.76-3.91) 2.45 (2.41-2.50)
Overall composite 3.96 (3.91-4.01) 4.61 (4.52-4.70) 2.97 (2.91-3.03)
Neonatal complications % (95% CI) % (95% CI) % (95% CI)
Mortality <7 days 0.10 (0.08-0.11) 0.20 (0.17-0.23) 0.04 (0.03-0.03)
Mortality <28 days 0.07 (0.05-0.09) 0.16 (0.13-0.20) 0.06 (0.05-0.07)
Neurologic symptoms 0.19 (0.17-0.22) 0.47 (0.39-0.53) 0.05 (0.05-0.06)
Life threatening composite 0.22 (0.19-0.24) 0.65 (0.54-0.76) 0.10 (0.08-0.11)
Pulmonary disorders 1.46 (1.37-1.54) 2.65 (2.45-2.84) 0.66 (0.61-0.70)
Bacterial infections 0.55 (0.52-0.58) 1.10 (0.98-1.22) 0.43 (0.40-0.46)
pH < 7.00 0.48 (0.46-0.49) 0.36 (0.33-0.38) 0.65 (0.61-0.69)
BD > 12 mmol/L 1.31 (1.28-1.34) 1.50 (1.46-1.54) 1.26 (1.22-1.30)
Apgar < 7 0.70 (0.67-0.72) 1.03 (0.91-1.15) 0.61 (0.57-0.64)
Other** 5.04 (4.81-5.27) 7.83 (7.33-8.33) 1.65 (1.49-1.82)
Non-life threatening composite 6.34 (6.11-6.58) 9.02 (8.52-9.52) 3.37 (3.15-3.58)
Overall composite 6.52 (6.34-6.71) 9.77 (9.38-10.16) 3.52 (3.35-3.68)
Footnotes. Outcomes were adjusted by maternal age, maternal body mass index, gestational age at delivery, pregnancy at risk, parity, fetal presentation, number
of fetuses, presence of previous CD, neonatal birth weight, grade of urgency (e.g. maternal or fetal compromise requiring immediate delivery) and cluster
variables: centers with NICU and obstetric volume per center (number of deliveries/year).
PPH, post-partum hemorrhage; TED, thromboembolic disease; BD, base deficit.
*Any other condition requiring admission to Intensive Care Unit.
**Any other condition requiring admission to Neonatal Intensive Care Unit in term neonates (37–42 weeks).
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and 3).
These results are of clinical relevance. As first, both
CD rates and AVD rates must be considered for a cor-
rect evaluation of the performance of every maternity
unit. If assisted vaginal deliveries are not considered as
part of the quality care assessment, the evaluation can
be misleading. Centers with CD rates within the ex-
pected can in fact be thought to provide a good care,
while they may actually dispense less optimal levels of
care if their AVD rates are found to be higher-than-expected. The status of center G represents an example:
the adjusted CD rate was within the expected and thus
associated with “good outcomes”, but its “above” AVD
rate was associated with an increased risk of complica-
tions. Second, both CD rates above and below the ex-
pected can be considered as an indicator of increased
risk of maternal or neonatal morbidities. In this regard,
it is clear that the best maternal and neonatal outcomes
are offered by those institutions, as center E, that main-
tain a CD rate within the expected range and have a
simultaneous low rate of AVD.
Figure 2 Forest plots of life threatening, non-life threatening and overall composite maternal and neonatal complications, by caesarean
delivery rates outlier status.
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cannot completely explain the differences in the most
severe adverse maternal and neonatal outcomes as ob-
served in different outlier status of operative deliveries.
In fact, if compared with SVD, as demonstrated in
other studies [25], AVDs were associated with an in-
creased risk of selected maternal and neonatal composite
adverse outcomes. Caesarean deliveries, instead, increased
only the risk of endometritis, newborn pulmonary disor-
ders and Apgar less than 7 at five minutes.
The causal link between above and below the expected
risk-adjusted CD rates and poorer maternal and espe-
cially neonatal outcomes is unclear. This relationship
does not imply causality, but suggests that an association
is present.
Despite the differences in study design, our results
support the conclusions of Gould, Bailit, Srinivas: insti-
tutional CD rates both “above” or “below” the expectedmay be considered as indicators of increased risk of ma-
ternal or neonatal morbidities. Gould et al. focused their
analysis only on outcomes of low risk pregnancies [5].
Bailit et al. evaluated the risk of adverse maternal and
neonatal outcomes by considering only the outlier status
for primary and not overall adjusted CD rates [6,7].
Srinivas et al. considered only selected measures of
complications, such as maternal wound infection, post-
partum hemorrhage, blood transfusion and neonatal mor-
tality, asphyxia or seizures [8]. The main limitation of
these studies was the model of risk adjusting outcomes.
All of them based their analyses on retrospective collec-
tion of pregnancy data derived from birth certificates and
hospital discharge records containing ICD-9 diagnoses
codes. Moreover they did not consider relevant variables
for risk adjustment such as, for example, maternal BMI,
obstetric volume and conditions of impeding maternal or
neonatal compromise. Medical records, birth certificates,
Figure 3 Forest plots of life threatening, non-life threatening and overall composite maternal and neonatal complications, by assisted
vaginal delivery rates outlier status.
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Classification of Diseases - 9th Revision (ICD-9) codes are
commonly used as resources for research and quality sur-
veillance in obstetric practice. However, these large data-
sets, which are usually used for other purposes such as for
insurances or health statistics, often lack the information
needed to homogenously risk-adjust the outcomes of
interest for patient characteristics. [21,22,26,27]. Even
though our study was not based on a large number of
deliveries, it should be considered as one of the few in
which the operative delivery rates and the incidence of
maternal and neonatal complications were adjusted for
unambiguous data. Information on maternal character-
istics, antenatal obstetric conditions/risk factors and
maternal/neonatal outcome variables was prospectively
gathered in a dedicated database that allowed us to col-
lect standardized and homogeneous data, excluding
only 3.6% of the records from the final analysis becauseof missing data. Nevertheless our study, by prospectively
collecting information on twelve maternal and ten neo-
natal adverse outcome variables, provided the information
that overall CD rates – not only primary – may be consid-
ered as a measure of quality of care.
In regard to the association of outlier status for CD
rates and neonatal morbidity, it might be hypothesized
that increased morbidity observed in the “below” CD
rate group might suggest that certain infants delivered
vaginally could potentially have benefited from caesarean
delivery. Alternatively, in these centers, an inappropriate
delayed timing in the conduction of the delivery might
have resulted in a higher rate of neonatal morbidity.
The increased rate of neonatal complications observed in
the “above” CD rate group might be explained considering
that the selection process in this group, though leading to
more caesarean deliveries, failed to consider many cases
that might have benefited from the caesarean delivery [5].
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models may vary between institutions and these might ac-
count for both different incidences of adverse outcomes
and operative delivery rates [23,24,28].
Walsh et al. observed that both AVDs and CDs in the
second stage of labor are associated with a similar
increased risk of serious neonatal complications [29]. In
our context, we may suppose that any inappropriate
anticipation of an obstetric intervention in the second
stage of labor, without respecting its “physiological” dur-
ation or without managing second stage according to
the recommended guidelines, might increase the rate of
both caesarean and operative deliveries and worsen the
obstetric outcomes [22,24,28].
The literature does not clarify whether the hospital de-
livery volume might influence both the rate of operative
deliveries and of maternal and neonatal complications
[18-20,30]. In this regard, it is possible that smaller units
might have a lower threshold for operative deliveries due
to organizational reasons and lack of resources required
to respond to medical emergencies. For the same rea-
sons, these institutions could also present worse out-
comes. This might not be the case of our study, because
inter institutional variations in operative delivery rates
and frequencies of adverse outcomes remained either
between centers with less than 1000 deliveries/year and
institutions with more than 1000 deliveries/year, despite
the inclusion of obstetric volume, of type of neonatal
organization (NICU availability) and delivery grade of
urgency (emergency – no emergency) into the adjusted
model. As suggested by Janakiraman et al., it might be
that the increased risk of maternal and neonatal compli-
cations could be related to hospital performance, inde-
pendently from delivery volumes [20].
Despite the clinically relevant conclusions, we are
aware that our study has its limitations. First, we did not
consider separately every antenatal risk factor, labeling
the pregnancy as “at risk” according to selected groups
of risk conditions. However, other studies adopted this
classification considering that a successful model for
adjusting assisted delivery rates should consider the
most relevant risk factors that must be acceptable to
practicing obstetricians [21-23,31]. Second, we did not
include other variables, such as race/ethnicity or socio-
economic status or habits (e.g. smoking), in the risk ad-
justment. However, the former was not assessed because
of the very low prevalence of non-Caucasians in our re-
gion and considering this variable should not have a
relevant role in the prediction of operative delivery [32];
the latter was not considered because the collected data
included all the clinical adverse conditions that are associ-
ated with “bad” habits (e.g. intrauterine growth restriction,
preterm delivery). Third, there is no wide agreement on
which indicators of outcome need to be evaluated toassess obstetric quality. In this regard, we considered
the short term clinically meaningful indicators that are
included in the Agency for Health Care Research and
Quality report, in the Adverse Outcome Index and in
the recent model proposed by Sibanda et al. on behalf
of the Royal College of Obstetricians and Gynaecolo-
gists [33-36]. Finally, a further limitation of our study
was the inability to assess what factors contributed to
adverse outcomes in the outlier settings. In this con-
text caesarean and assisted vaginal deliveries might
reflect the differences to a selected processes of care
(e.g. training, adherence to guidelines) that might explain
inter-institutional variation of outcomes [30]. Nonetheless
the aim of our study was not to measure the process of
care, but to evaluate whether variations of both CD and
AVD rates among institutions could explain differences in
outcomes.
Conclusions
Our results support the belief that evaluating the CD
rates without taking into account the AVD rates might
not provide a reliable view of obstetric performance. In
this context, the case-mix adjustment for a complete
and standardized set of variables and the knowledge of
the outlier status for both assisted vaginal and caesarean
deliveries are crucial to properly assess the level of care
among institutions, giving the opportunity to modify the
management and improve the outcomes [4,37].
However we are aware that more research is required
to develop a consensus about accepted, reproducible and
clinically relevant indicators of maternal and neonatal
outcomes that need to be evaluated in the process of
labor audit [38].
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